Dylan-Hyde Tyler

CIK 00016820271 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001682027

Recent Transactions

39 trades

Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-16$12.57/sh+19,890→ 45,094 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-16$28.24/sh−1,110→ 25,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-16$28.00/sh−45,000→ 25,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-01-16−19,890→ 5,237 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-16$12.57/sh+1,110→ 26,314 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-01-16−1,110→ 36,663 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-16$28.10/sh−19,890→ 25,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-02$25.75/sh−8,000→ 70,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-01-02−6,490→ 37,773 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-01-02−1,510→ 25,157 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-02$20.55/sh−30,000→ 70,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2018-01-02$12.57/sh+8,000→ 78,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$21.75/sh−6,230→ 115,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$14.43/sh+6,230→ 121,434 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$12.57/sh+9,070→ 124,274 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$22.68/sh−15,000→ 100,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$21.75/sh−1,070→ 123,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-12-29−9,070→ 44,263 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-29$23.76/sh−8,000→ 115,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-12-29−6,230→ 58,070 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-28$21.75/sh−700→ 115,204 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-28$14.43/sh+700→ 115,904 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-12-28−700→ 64,300 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-22$20.55/sh−15,000→ 115,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-12-15$18.90/sh−15,000→ 130,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-08-08$18.60/sh−1,313→ 153,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-08-07$18.56/sh−13,210→ 154,517 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-08-04$18.55/sh−477→ 167,727 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2017-06-15+65,000→ 65,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-05-01$16.61/sh−1,852→ 168,204 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-28$16.62/sh−4,912→ 170,056 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-27$16.84/sh−13,527→ 174,968 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-26$16.76/sh−3,200→ 180,495 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-25$16.87/sh−4,800→ 183,695 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-24$16.44/sh−3,522→ 188,495 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-21$17.02/sh−3,010→ 192,017 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-20$17.37/sh−2,937→ 195,027 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-19$18.58/sh−2,310→ 197,964 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2017-04-19$17.49/sh−4,930→ 200,274 total

Companies

CRISPR Therapeutics AG
Chief Legal Officer
$CRSP

Recent Filings

Address

C/O CRISPR THERAPEUTICS, INC. 200 SIDNEY ST.

CAMBRIDGE, MA, 02139

View on SEC.gov